Solid Biosciences Inc. — Director's Dealing 2025

Feb 18, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2025-02-13

Reporting Person: Ganot Ilan (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-13	Common Stock	M	4861	—	Acquired	16550	Indirect
2025-02-14	Common Stock	S	1711	$3.96	Disposed	14839	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-13	Restricted Stock Units	$	M	4861	Disposed		Common Stock (4861)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	98690	Direct
Common Stock	19394	Indirect

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: Represents 94,648 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.

F3: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot.

F4: Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.

F5: On February 13, 2024 (the "Grant Date") Ms. Ganot was granted 19,444 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.